The national “Moonshot” initiative is repeatedly making news headlines as the $1 billion effort designed to eliminate cancer has groundbreaking potential. Led by Vice President Joe Biden, the effort is focused on accelerating research and making more therapies available – and blood cancer patients have much to gain.
I recently joined an expert panel at the annual Milken Institute Global Conference, “Promise of the Cancer Moonshot,” to share The Leukemia & Lymphoma Society’s (LLS) perspective about what needs to be done to move this effort forward.
I was in good company.
Other speakers included Anna Barker, a professor and director of Arizona State University's Transformative Healthcare Networks; Michelle Bennett, director, Center for Research Strategy, National Cancer Institute; Robert Bradway, chairman and CEO, Amgen; and Isla Garraway, associate professor and director of research at the University of California, Los Angeles. The panel was moderated by Kathy Hudson, deputy director for science, outreach and policy, National Institutes of Health.